» Articles » PMID: 19770216

Local and Remote Epileptogenicity in Focal Cortical Dysplasias and Neurodevelopmental Tumours

Overview
Journal Brain
Specialty Neurology
Date 2009 Sep 23
PMID 19770216
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

During the pre-surgical evaluation of drug-resistant epilepsy, the assessment of the extent of the epileptogenic zone and its organization is a crucial objective. Indeed, the epileptogenic zone may be organized as a simple focal lesional site or as a more complex network (often referred to as the 'epileptogenic network') extending beyond the lesion. This distinction is particularly relevant in developmental lesions such as focal cortical dysplasias or dysembryoplastic neuroepithelial tumours and may determine both the surgical strategy and the prognosis. In this study, we have quantified the epileptogenic characteristic of brain structures explored by depth electrodes in 36 patients investigated by stereoelectroencephalography and suffering from focal drug-resistant epilepsy associated with focal cortical dysplasias or dysembryoplastic neuroepithelial tumours. This quantification was performed using the 'Epileptogenicity Index' method that accounts for both the propensity of a brain area to generate rapid discharges and the time for this area to get involved in the seizure. Epileptogenicity Index values range from 0 (no epileptogenicity) to 1 (maximal epileptogenicity). We determined Epileptogenicity Index from signals recorded in distinct brain structures including the lesional site. We studied the type of epileptogenic zone organization (focal versus network) and looked for a correlation with clinical data and post-surgical outcome. Mean Epileptogenicity Index in lesional regions was 0.87 (+/-0.25), and 0.29 (+/-0.30) in 'non-lesional' structures. The number of highly epileptogenic structures (defined by Epileptogenicity Index value >or=0.4) was 3.14 (+/-1.87) in the whole population. We found that 31% of patients had only one epileptogenic structure (N(EI>or=0.4) = 1), therefore disclosing a strictly focal epileptogenic zone organization while 25 patients had more than one epileptogenic region, disclosing a network (61%) or bilateral (8%) epileptogenic zone organization. We observed a trend for a difference in seizure outcome according to the type of epileptogenic zone organization. Indeed, 57% of patients with network organization and 87% with focal organization were seizure-free while none of those with bilateral organization became seizure-free. The determination of Epileptogenicity Index computed from electrophysiological signals recorded according to the stereoelectroencephalography technique is a novel tool. Results suggest that it can help in the delineation of the epileptogenic zone associated with brain lesions and that it could be used in the definition of the subsequent surgical resection.

Citing Articles

Epileptogenic zone characteristics determine effectiveness of electrical transcranial stimulation in epilepsy treatment.

Daoud M, Medina-Villalon S, Garnier E, Bratu I, Damiani G, Salvador R Brain Commun. 2025; 7(1):fcaf012.

PMID: 39974175 PMC: 11837341. DOI: 10.1093/braincomms/fcaf012.


Surgical treatment of long-term epilepsy-associated tumors guided by stereoelectroencephalography.

Zhang W, Guo Q, Chen J, Zhu D, Tan Q, Zhang L Eur J Med Res. 2024; 29(1):512.

PMID: 39444045 PMC: 11515466. DOI: 10.1186/s40001-024-02097-8.


MEG in MRI-Negative Patients with Focal Epilepsy.

Kreidenhuber R, Poppert K, Mauritz M, Hamer H, Delev D, Schnell O J Clin Med. 2024; 13(19).

PMID: 39407806 PMC: 11476570. DOI: 10.3390/jcm13195746.


Clinical characteristics and post-operative outcomes in children with malformation of cortical development related drug-resistant epilepsy: 428 cases in one pediatric epilepsy center.

Yu H, Sun Y, Liu C, Wang Y, Liu Q, Ji T CNS Neurosci Ther. 2024; 30(9):e70031.

PMID: 39233349 PMC: 11374691. DOI: 10.1111/cns.70031.


Generalisability of epileptiform patterns across time and patients.

Karimi-Rouzbahani H, McGonigal A Sci Rep. 2024; 14(1):6293.

PMID: 38491096 PMC: 10942983. DOI: 10.1038/s41598-024-56990-7.